Works matching IS 09024441 AND DT 2021 AND VI 107 AND IP 6

Results: 9

Transitioning tacrolimus to sirolimus in allogeneic hematopoietic cell transplantation.

Published in:

European Journal of Haematology, 2021, v. 107, n. 6, p. 634, doi. 10.1111/ejh.13701

By:

Arrabi, Linda;
Jan, Anna;
Hosing, Chitra;
Milton, Denái R.;
Yeh, Jason

Publication type:

Article

Immune‐related adverse events in cancer patients being treated with immune checkpoint inhibitors.

Published in:

European Journal of Haematology, 2021, v. 107, n. 6, p. 650, doi. 10.1111/ejh.13703

By:

Byrne, Margaret M.;
Lucas, Mathew;
Pai, Lori;
Breeze, Janis;
Parsons, Susan K.

Publication type:

Article

Novel somatic alterations in unicentric and idiopathic multicentric Castleman disease.

Published in:

European Journal of Haematology, 2021, v. 107, n. 6, p. 642, doi. 10.1111/ejh.13702

By:

Goodman, Aaron M.;
Jeong, Ah‐Reum;
Phillips, Alexis;
Wang, Huan‐You;
Sokol, Ethan S.;
Cohen, Philip R.;
Sicklick, Jason;
Fajgenbaum, David C.;
Kurzrock, Razelle

Publication type:

Article

Data‐driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

Published in:

European Journal of Haematology, 2021, v. 107, n. 6, p. 624, doi. 10.1111/ejh.13700

By:

Dam, Marc J. B.;
Pedersen, Rasmus K.;
Knudsen, Trine A.;
Andersen, Morten;
Skov, Vibe;
Kjær, Lasse;
Hasselbalch, Hans C.;
Ottesen, Johnny T.

Publication type:

Article

Long‐term tolerability and efficacy after initial PegIFN‐α addition to dasatinib in CML‐CP: Five‐year follow‐up of the NordCML007 study.

Published in:

European Journal of Haematology, 2021, v. 107, n. 6, p. 617, doi. 10.1111/ejh.13699

By:

Flygt, Hjalmar;
Söderlund, Stina;
Stentoft, Jesper;
Richter, Johan;
Koskenvesa, Perttu;
Mustjoki, Satu;
Majeed, Waleed;
Lübking, Anna;
Dreimane, Arta;
Markevärn, Berit;
Stenke, Leif;
Myhr Eriksson, Kristina;
Gjertsen, Bjørn Tore;
Gedde‐Dahl, Tobias;
Dimitrijevic, Andreja;
Udby, Lene;
Olsson‐Strömberg, Ulla;
Hjorth‐Hansen, Henrik

Publication type:

Article

Acquisition of IDH2 mutations in relapsed/refractory AML is associated with worse patient outcomes.

Published in:

European Journal of Haematology, 2021, v. 107, n. 6, p. 609, doi. 10.1111/ejh.13698

By:

Song, Amy;
Altabbakh, Omar;
Sallman, David A.;
Padron, Eric;
Talati, Chetasi;
Hussaini, Mohammad O.

Publication type:

Article

Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple‐class relapsed/refractory multiple myeloma (RRMM).

Published in:

European Journal of Haematology, 2021, v. 107, n. 6, p. 602, doi. 10.1111/ejh.13697

By:

Pennipede, Dante;
Mohyuddin, Ghulam Rehman;
Hawkins, Ryan;
Ganguly, Siddhartha;
Shune, Leyla;
Ahmed, Nausheen;
Mohan, Meera;
Cui, Wei;
Mahmoudjafari, Zahra;
McGuirk, Joseph;
Atrash, Shebli;
Abdallah, Al‐Ola

Publication type:

Article

Post‐transplantation erythrocytosis in kidney transplant recipients—A retrospective cohort study.

Published in:

European Journal of Haematology, 2021, v. 107, n. 6, p. 595, doi. 10.1111/ejh.13696

By:

Hofstetter, Liron;
Rozen‐Zvi, Benaya;
Schechter, Amir;
Raanani, Pia;
Itzhaki, Oranit;
Rahamimov, Ruth;
Gafter‐Gvili, Anat

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2021, v. 107, n. 6, p. 593, doi. 10.1111/ejh.13452
Publication type:: Article